Annual ROE
-31.90%
-350.59%-110.01%
December 31, 2023
Summary
- As of February 7, 2025, TXMD annual return on equity is -31.90%, with the most recent change of -350.59% (-110.01%) on December 31, 2023.
- During the last 3 years, TXMD annual ROE has fallen by -179.90% (-121.55%).
- TXMD annual ROE is now -101.30% below its all-time high of 2450.65%, reached on December 31, 2012.
Performance
TXMD ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-11.78%
+9.22%+43.90%
September 30, 2024
Summary
- As of February 7, 2025, TXMD quarterly return on equity is -11.78%, with the most recent change of +9.22% (+43.90%) on September 30, 2024.
- Over the past year, TXMD quarterly ROE has increased by +21.23% (+64.31%).
- TXMD quarterly ROE is now -100.06% below its all-time high of 20.28 thousand%, reached on September 30, 2011.
Performance
TXMD Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TXMD ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -110.0% | +64.3% |
| 3 y3 years | -121.5% | +99.9% |
| 5 y5 years | +72.7% | +99.9% |
TXMD ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -110.0% | at low | -101.3% | +99.9% |
| 5 y | 5-year | -110.0% | +90.3% | -101.3% | +99.9% |
| alltime | all time | -101.3% | +96.4% | -100.1% | +99.9% |
TherapeuticsMD ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -11.78%(-43.9%) |
| Jun 2024 | - | -21.00%(-15.4%) |
| Mar 2024 | - | -24.83%(-24.8%) |
| Dec 2023 | -31.90%(-110.0%) | -33.01%(-107.6%) |
| Sep 2023 | - | 437.05%(-50.8%) |
| Jun 2023 | - | 889.00%(-110.1%) |
| Mar 2023 | - | -8781.87%(+3424.0%) |
| Dec 2022 | 318.69%(+73.1%) | -249.20%(-2319.1%) |
| Sep 2022 | - | 11.23%(-67.1%) |
| Jun 2022 | - | 34.15%(-84.0%) |
| Mar 2022 | - | 213.78%(-35.0%) |
| Dec 2021 | 184.16%(+24.4%) | 329.14%(+15.1%) |
| Sep 2021 | - | 286.01%(+36.2%) |
| Jun 2021 | - | 209.97%(+8.6%) |
| Mar 2021 | - | 193.31%(-0.1%) |
| Dec 2020 | 148.00%(-144.8%) | 193.52%(-37.6%) |
| Sep 2020 | - | 310.20%(-38.3%) |
| Jun 2020 | - | 502.83%(-106.0%) |
| Mar 2020 | - | -8375.90%(+1367.3%) |
| Dec 2019 | -330.09%(+183.0%) | -570.85%(+92.0%) |
| Sep 2019 | - | -297.35%(+32.5%) |
| Jun 2019 | - | -224.48%(+45.1%) |
| Mar 2019 | - | -154.75%(+27.5%) |
| Dec 2018 | -116.62%(+95.1%) | -121.33%(+26.7%) |
| Sep 2018 | - | -95.79%(+14.0%) |
| Jun 2018 | - | -84.00%(+23.8%) |
| Mar 2018 | - | -67.87%(+7.8%) |
| Dec 2017 | -59.77%(-36.6%) | -62.97%(+0.8%) |
| Sep 2017 | - | -62.44%(-9.2%) |
| Jun 2017 | - | -68.75%(+12.1%) |
| Mar 2017 | - | -61.31%(-6.2%) |
| Dec 2016 | -94.33%(-38.2%) | -65.36%(-1.4%) |
| Sep 2016 | - | -66.28%(-7.0%) |
| Jun 2016 | - | -71.25%(-20.5%) |
| Mar 2016 | - | -89.65%(-28.4%) |
| Dec 2015 | -152.67%(+45.1%) | -125.21%(+1.6%) |
| Sep 2015 | - | -123.28%(-10.0%) |
| Jun 2015 | - | -137.01%(+18.0%) |
| Mar 2015 | - | -116.10%(+7.5%) |
| Dec 2014 | -105.19%(-1.4%) | -108.04%(+23.5%) |
| Sep 2014 | - | -87.47%(+15.9%) |
| Jun 2014 | - | -75.44%(+16.8%) |
| Mar 2014 | - | -64.57%(-12.0%) |
| Dec 2013 | -106.71%(-104.4%) | -73.38%(-23.3%) |
| Sep 2013 | - | -95.69%(-38.4%) |
| Jun 2013 | - | -155.45%(-66.8%) |
| Mar 2013 | - | -468.25%(-132.7%) |
| Dec 2012 | 2450.65%(+224.9%) | 1430.05%(-7.3%) |
| Sep 2012 | - | 1543.36%(-34.0%) |
| Jun 2012 | - | 2336.96%(+34.3%) |
| Mar 2012 | - | 1740.20%(-6.1%) |
| Dec 2011 | 754.33% | 1853.46%(-90.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | 20.28 K%(+555.0%) |
| Jun 2011 | - | 3096.84%(+147.9%) |
| Mar 2011 | - | 1249.30%(+54.6%) |
| Dec 2010 | -877.76%(-265.0%) | 808.23%(+347.1%) |
| Sep 2010 | - | 180.78%(-56.0%) |
| Jun 2010 | - | 411.21%(-41.9%) |
| Mar 2010 | - | 707.86%(-71.1%) |
| Dec 2009 | 531.82%(-393.3%) | 2446.59%(-252.0%) |
| Sep 2009 | - | -1609.67%(+190.1%) |
| Jun 2009 | - | -554.88%(+30.6%) |
| Mar 2009 | - | -424.96%(+91.0%) |
| Dec 2008 | -181.35%(-1219.4%) | -222.47%(+189.4%) |
| Sep 2008 | - | -76.86%(+144.0%) |
| Jun 2008 | - | -31.50%(-568.8%) |
| Mar 2008 | - | 6.72%(-40.5%) |
| Dec 2007 | 16.20%(+78.8%) | 11.29%(+243.2%) |
| Sep 2007 | - | 3.29%(-54.1%) |
| Jun 2007 | - | 7.16%(-14.5%) |
| Mar 2007 | - | 8.37%(-7.9%) |
| Dec 2006 | 9.06%(-66.9%) | 9.09%(-69.5%) |
| Sep 2006 | - | 29.79%(+3.8%) |
| Jun 2006 | - | 28.70%(+16.5%) |
| Mar 2006 | - | 24.63%(-10.6%) |
| Dec 2005 | 27.34%(+84.5%) | 27.54%(+8.0%) |
| Sep 2005 | - | 25.49%(+17.7%) |
| Jun 2005 | - | 21.65%(-12.0%) |
| Mar 2005 | - | 24.61%(+61.9%) |
| Dec 2004 | 14.82%(+26.1%) | 15.20%(+57.0%) |
| Sep 2004 | - | 9.68%(+12.6%) |
| Jun 2004 | - | 8.60%(+21.8%) |
| Mar 2004 | - | 7.06%(-40.2%) |
| Dec 2003 | 11.75%(-16.4%) | 11.80%(-11.7%) |
| Sep 2003 | - | 13.36%(+17.7%) |
| Jun 2003 | - | 11.35%(-7.6%) |
| Mar 2003 | - | 12.28%(-14.1%) |
| Dec 2002 | 14.05%(+46.7%) | 14.29%(+141.8%) |
| Sep 2002 | - | 5.91%(+36.5%) |
| Jun 2002 | - | 4.33%(-34.7%) |
| Mar 2002 | - | 6.63%(-28.5%) |
| Dec 2001 | 9.58%(+65.2%) | 9.27%(+11.7%) |
| Sep 2001 | - | 8.30%(-35.5%) |
| Jun 2001 | - | 12.86%(+20.1%) |
| Mar 2001 | - | 10.71%(+78.2%) |
| Dec 2000 | 5.80%(+118.9%) | 6.01%(-50.5%) |
| Sep 2000 | - | 12.14%(+64.3%) |
| Jun 2000 | - | 7.39%(+16.9%) |
| Mar 2000 | - | 6.32%(+145.0%) |
| Dec 1999 | 2.65%(-181.3%) | 2.58% |
| Dec 1998 | -3.26%(+28.9%) | - |
| Dec 1997 | -2.53%(-116.3%) | - |
| Dec 1996 | 15.51%(+111.6%) | - |
| Dec 1995 | 7.33%(-10.2%) | - |
| Dec 1994 | 8.16% | - |
FAQ
- What is TherapeuticsMD annual return on equity?
- What is the all time high annual ROE for TherapeuticsMD?
- What is TherapeuticsMD annual ROE year-on-year change?
- What is TherapeuticsMD quarterly return on equity?
- What is the all time high quarterly ROE for TherapeuticsMD?
- What is TherapeuticsMD quarterly ROE year-on-year change?
What is TherapeuticsMD annual return on equity?
The current annual ROE of TXMD is -31.90%
What is the all time high annual ROE for TherapeuticsMD?
TherapeuticsMD all-time high annual return on equity is 2450.65%
What is TherapeuticsMD annual ROE year-on-year change?
Over the past year, TXMD annual return on equity has changed by -350.59% (-110.01%)
What is TherapeuticsMD quarterly return on equity?
The current quarterly ROE of TXMD is -11.78%
What is the all time high quarterly ROE for TherapeuticsMD?
TherapeuticsMD all-time high quarterly return on equity is 20.28 K%
What is TherapeuticsMD quarterly ROE year-on-year change?
Over the past year, TXMD quarterly return on equity has changed by +21.23% (+64.31%)